Stock Appreciation Rights, explained plainly.
Faure does not pay session fees. Completed sessions carry grants of Stock Appreciation Rights in Brox AI, Inc., the research company whose products your insights help power. This page explains what that means, without the varnish.
- The instrument
- SARs in Brox AI, Inc. Not cash, not shares, not options
- Video interview
- A grant with an initial notional value of $500
- AI voice conversation
- A grant with an initial notional value of $5 per minute
Initial notional values are the sizing basis of a grant, not amounts payable. As with any early-stage company, there is no guarantee of future value, and SARs may ultimately be worth nothing.
What a SAR actually is
A Stock Appreciation Right is a contractual right whose value tracks the appreciation of Brox stock. If the value of the company rises after your grant, the value of your SARs rises with it.
SARs are granted under an individual SAR agreement you receive after your application is approved. The agreement, not this page, governs your grants: it states each grant's initial notional value, any vesting conditions, and how and when SARs settle.
As with any early-stage company, there is no guarantee of future value, and SARs may ultimately be worth nothing. We would rather you join with that sentence in mind than discover it in the small print.
- Not shares, not optionsYou do not own equity in Brox and there is nothing to exercise. The right tracks appreciation only.
- Never a purchaseYou never pay anything, for the grant or at any point after it. There is no buy-in and nothing to fund.
- Granted per completed sessionEach completed session carries its own grant, recorded under your SAR agreement with a stated initial notional value.
- Settlement per your agreementHow and when SARs settle is set out in the SAR agreement you countersign after approval.
How grants are sized
Every grant starts from a stated initial notional value. That value is the measure the grant is sized against on the day it is made; it is not a payment, and what the grant is eventually worth depends on how Brox performs from there.
| Session | Sized at |
|---|---|
| Video interviewRoughly 45 minutes, one to one with our research team. | $500initial notional value per interview |
| AI voice conversation5 to 30 minutes, in our iOS app or in the browser. | $5initial notional value per minute |
| Typical monthEntirely at your own pace. There is no minimum commitment. | 2 to 4sessions |
Initial notional values are the sizing basis of a grant, not amounts payable. As with any early-stage company, there is no guarantee of future value, and SARs may ultimately be worth nothing.
Because a few hundred dollars per session is unlikely to be why someone like you would do this.
Pretending otherwise would be patronising. The honest version of the exchange is alignment: your conversations, anonymised and aggregated, make Brox's research products better, and in return you hold rights that track the value of the company you are helping to grow.
Brox AI, Inc. builds behavioural digital twins of real people from research conversations. Roughly twenty enterprise clients commission research built on them, across pharmaceutical, financial services, consumer, sports, and entertainment categories. We never name clients, and no client is ever told who you are.
The caveat belongs next to the upside, so here it is again: as with any early-stage company, there is no guarantee of future value, and SARs may ultimately be worth nothing.
From session to grant
The mechanics are deliberately simple, and nothing about them requires action from you beyond the conversations themselves.
-
You are approved and receive your SAR agreement
One agreement governs all of your grants. Read it, sign it, and keep it; it is the document your rights come from.
-
You complete a session
A video interview, an AI voice conversation, or an in-person evening. Sessions you decline or leave unfinished simply carry no grant.
-
The grant is recorded
Each completed session is recorded as a SAR grant under your agreement, with its initial notional value stated at the time of grant.
-
Value tracks Brox from there
Your SARs track the appreciation of Brox stock from the grant date, and settle per the terms of your agreement. There is no guarantee of future value.
The questions worth asking
What will my SARs be worth?
That depends entirely on how Brox performs. Brox is growing in clients, revenue, and product, and SARs exist so that the people whose insights power that growth hold a share of it: if the value of the company rises, the value of your grant rises with it. We will be straight with you, though. As with any early-stage company, there is no guarantee of future value, and SARs may ultimately be worth nothing.
Do SARs have tax consequences?
They may. Depending on your circumstances and jurisdiction, SAR settlement can be a taxable event. Faure does not provide tax advice; please consult your own adviser.
How do vesting and settlement work?
Per your individual SAR agreement. The agreement you receive after approval states the terms that govern your grants, including any vesting conditions and the circumstances in which SARs settle.
Can I sell or transfer my SARs?
No. SARs are not transferable and there is no market for them. We make no promise of liquidity; settlement follows the terms of your agreement.
Can I take cash instead?
No. Faure compensates in SARs only. If a per-session fee is what you are looking for, a traditional panel will serve you better, and we would rather say that plainly than persuade you otherwise.
Do I ever pay anything?
Never. SARs are granted for completed sessions. They are not a purchase, there is no buy-in, and Faure will never ask you for money.
Nothing on this page is investment, legal, or tax advice, and nothing here modifies the SAR agreement itself. Questions the agreement does not answer: legal@faure.ai.
The terms suit some people and not others
If they suit you, we would like to read your application. Every one is reviewed by a person.
The application takes a few minutes and commits you to nothing.